Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure, or therapeutic abstention? A decision analytic perspective
- 1 March 1998
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 135 (3) , 532-541
- https://doi.org/10.1016/s0002-8703(98)70332-1
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Stroke recurrence in patients with patent foramen ovaleNeurology, 1996
- The Incidence of Patent Foramen Ovale in 1,000 Consecutive PatientsChest, 1995
- Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.Stroke, 1993
- The Prevalence of Deep Venous Thrombosis in Patients with Suspected Paradoxical EmbolismAnnals of Internal Medicine, 1993
- Patent foramen ovale: is stroke due to paradoxical embolism?Stroke, 1993
- Patent Foramen Ovale as a Risk Factor for Cryptogenic StrokeAnnals of Internal Medicine, 1992
- Cardiac sources of embolism and cerebral infarction—clinical consequences and vascular concomitantsNeurology, 1991
- PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTSThe Lancet, 1988
- Prevalence of Patent Foramen Ovale in Patients with StrokeNew England Journal of Medicine, 1988
- Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events.Stroke, 1987